The femtech company Ovulai develops a digital treatment app for women with chronic gynecological diseases. The team shares a passion for improving an under-prioritized area; women's health. They are data-driven women of tech, and most of them have studied at KTH.
Have you heard of the Apotekarsocieteten? If not, we are an independent non-profit association focusing on medicines being developed and used in the best way. It's a broad and vital area to cover, and it includes many steps in the drug chain that must function and work together.
Since a couple of months Peter Hovstadius is the new Chief Medical Officer at XNK Therapeutics, responsible for leading the medical development of the company's products. XNK operates in biotechnology and develops cell therapies (ATMP) using natural killer cells (NK cells) for cancer treatment.